HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming-Ming Yuan Selected Research

Ming-Ming Yuan Research Topics

Disease

2Adenocarcinoma of Lung
09/2021 - 05/2019
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2021 - 05/2019
1Lung Injury
01/2024
1Wounds and Injuries (Trauma)
01/2024
1COVID-19
01/2024
1Infections
08/2022
1Cardiomyopathies (Cardiomyopathy)
01/2022
1Pathologic Processes
12/2021
1Vascular Diseases (Vascular Disease)
12/2021
1Aortic Dissection
12/2021
1Disease Progression
09/2021
1Brain Neoplasms (Brain Tumor)
09/2021
1Iron Deficiencies
01/2021
1Familial Primary Pulmonary Hypertension
01/2021
1Atherosclerosis
01/2021

Drug/Important Bio-Agent (IBA)

1Cell-Free Nucleic AcidsIBA
01/2024
1Messenger RNA (mRNA)IBA
08/2022
1Toll-Like Receptors (Toll-Like Receptor)IBA
08/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
11,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA
12/2021
1olaparibIBA
09/2021
1EndostatinsIBA
09/2021
1Gefitinib (Iressa)FDA Link
09/2021
1IronIBA
01/2021
12,5- dibromo- 2- (beta- naphthyl)indan- 1,3- dioneIBA
01/2021
1ErbB Receptors (EGF Receptor)IBA
05/2019
1Tyrosine Kinase InhibitorsIBA
05/2019
1osimertinibIBA
05/2019

Therapy/Procedure

1Therapeutics
09/2021
1Immunotherapy
09/2021
1Chemoradiotherapy
09/2021